A Trial for Evaluating Both Safety and Preliminary Efficacy of a Single Infusion of Stimulated Autologous CD4+T Cells in Patients With Relapsing- Remitting Multiple Sclerosis

Summary

The purpose of this study is to assess the safety and the preliminary efficacy of a single infusion of stimulated autologous CD4+ T cells in patients with Relapsing-Remitting Multiple Sclerosis. The study duration for the patients (from start of baseline to end of follow-up) is 270 days.

Timeline

Start

2015-01

Primary completion

2016-08

Completion

2016-08

Outcome

Outcome not reported

Stopped (Enrollment): “study ended prior enrollment of the first patient because of unexpected issues in the manufacturing process prevented production of adequate clinical batches”

Drugs

Indications